Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
Open-market buys, last 90 days
$49,596
in 12 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,596. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Equels Thomas K +$50K CEO & President 12 filings

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-03 LINTAL ELLEN M Chief Financial Officer Grant or award · Options +50,000 50,000
2021-11-30 LINTAL ELLEN M Chief Financial Officer Grant or award · Options +100,000 100,000
2020-12-09 LINTAL ELLEN M Chief Financial Officer Grant or award · Options +75,000 75,000
2019-12-31 LINTAL ELLEN M CFO Grant or award +3,931 $0.53 $2K 22,892
2019-12-13 LINTAL ELLEN M CFO Grant or award +4,789 $0.44 $2K 18,961
2019-11-29 LINTAL ELLEN M CFO Grant or award +5,208 $0.40 $2K 14,172
2019-11-15 LINTAL ELLEN M CFO Grant or award +4,433 $0.47 $2K 8,964
2019-10-31 LINTAL ELLEN M CFO Grant or award +4,167 $0.50 $2K 4,531

Page 1 of 1 · 8 trades